<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>Value Research Online</title>
        <atom:link href="/stories/stock/41608/cipla-ltd/rss/" rel="self" type="application/rss+xml" />
        <link>https://www.valueresearchonline.com/</link>
        <description>RSS Feeds | Value Research</description>
        <language>en</language>
        <copyright>Copyright 2026 Value Research India Private Limited.</copyright>
        <image>
            <title>Value Research</title>
            <url>https://www.valueresearchonline.com/assets/images/valueresearchonline-desktop.png</url>
            <link>https://www.valueresearchonline.com/</link>
        </image>

        <item>
			<title>Fall of Pharma</title>
			<link>https://www.valueresearchonline.com/stories/32267/fall-of-pharma/</link>
			<pubDate>Thu, 13 Oct 2016 12:22:16 +0530</pubDate>
			<category>Marketwire</category>
			<description>The pharma sector, which once used to be the star of the Street, has been witnessing bad times></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/32267/fall-of-pharma/</guid>
		</item>
		<item>
			<title>Challenge the equity-return assumption</title>
			<link>https://www.valueresearchonline.com/stories/31633/challenge-the-equity-return-assumption/</link>
			<pubDate>Thu, 28 Jul 2016 08:00:00 +0530</pubDate>
			<category>Top of Mind</category>
			<description>Why you can no longer rely on 15-20 per cent returns from Indian equity markets></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/31633/challenge-the-equity-return-assumption/</guid>
		</item>
		<item>
			<title>FIIs Vs DIIs: Different strokes</title>
			<link>https://www.valueresearchonline.com/stories/31127/fiis-vs-diis-different-strokes/</link>
			<pubDate>Fri, 20 May 2016 10:30:00 +0530</pubDate>
			<category>Stockwire</category>
			<description>An analysis of stock market transactions reveals that FIIs and domestic institutions are taking contrasting views on sectors></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/31127/fiis-vs-diis-different-strokes/</guid>
		</item>
		<item>
			<title>The quest for value</title>
			<link>https://www.valueresearchonline.com/stories/29141/the-quest-for-value/</link>
			<pubDate>Tue, 20 Oct 2015 17:56:55 +0530</pubDate>
			<category>Marketwire</category>
			<description>&lt;img src=&quot;https://www.valueresearchonline.com/content-assets/images/29141_29141__w320__h240__.jpg&quot; alt=&quot;The quest for value&quot; border=&quot;0&quot; width=&quot;320&quot; height=&quot;240&quot; style=&quot;float: left; margin-right: 5px;&quot;&gt;There is little value in the stocks of the three main defensive sectors: FMCG, pharma and technology</description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/29141/the-quest-for-value/</guid>
		</item>
		<item>
			<title>Gaining on healthy demand</title>
			<link>https://www.valueresearchonline.com/stories/28717/gaining-on-healthy-demand/</link>
			<pubDate>Wed, 09 Sep 2015 01:00:00 +0530</pubDate>
			<category>Stock Analyst Choice</category>
			<description>Cipla saw a number of management changes in the past couple of years, but it has now entered into the growth phase again></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/28717/gaining-on-healthy-demand/</guid>
		</item>
		<item>
			<title>Five stocks poised for take-off</title>
			<link>https://www.valueresearchonline.com/stories/28710/five-stocks-poised-for-take-off/</link>
			<pubDate>Tue, 08 Sep 2015 08:00:00 +0530</pubDate>
			<category>Stockwire</category>
			<description>We bring you 4 stocks that are on an improvement course and would make a good investment case at this stage></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/28710/five-stocks-poised-for-take-off/</guid>
		</item>
		<item>
			<title>Does opportunity buying work?</title>
			<link>https://www.valueresearchonline.com/stories/28229/does-opportunity-buying-work/</link>
			<pubDate>Wed, 24 Jun 2015 12:40:03 +0530</pubDate>
			<category>Stockwire</category>
			<description>&lt;img src=&quot;https://www.valueresearchonline.com/content-assets/images/28229_28229__w320__h240__.jpg&quot; alt=&quot;Does opportunity buying work?&quot; border=&quot;0&quot; width=&quot;320&quot; height=&quot;240&quot; style=&quot;float: left; margin-right: 5px;&quot;&gt;Buying distressed stocks may not always yield good returns</description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/28229/does-opportunity-buying-work/</guid>
		</item>
		<item>
			<title>The Ben Graham Way</title>
			<link>https://www.valueresearchonline.com/stories/27759/the-ben-graham-way/</link>
			<pubDate>Mon, 27 Apr 2015 15:55:02 +0530</pubDate>
			<category>Stockwire</category>
			<description>&lt;img src=&quot;https://www.valueresearchonline.com/content-assets/images/27759_27759__w320__h240__.jpg&quot; alt=&quot;The Ben Graham Way&quot; border=&quot;0&quot; width=&quot;320&quot; height=&quot;240&quot; style=&quot;float: left; margin-right: 5px;&quot;&gt;We tweak Benjamin Graham&#039;s simple formula for finding approximate valuations for growth stocks to make it work for Indian investors</description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/27759/the-ben-graham-way/</guid>
		</item>
		<item>
			<title>Fighting Fit</title>
			<link>https://www.valueresearchonline.com/stories/27132/fighting-fits/</link>
			<pubDate>Tue, 10 Feb 2015 11:43:00 +0530</pubDate>
			<category>Stockwire</category>
			<description>&lt;img src=&quot;https://www.valueresearchonline.com/content-assets/images/27132_27132__w320__h240__.jpg&quot; alt=&quot;Fighting Fit&quot; border=&quot;0&quot; width=&quot;320&quot; height=&quot;240&quot; style=&quot;float: left; margin-right: 5px;&quot;&gt;Robust sales in the US along with recovery in the domestic market drives earnings for the pharma sector</description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/27132/fighting-fits/</guid>
		</item>
		<item>
			<title>Institutional Holding Nearing Limit</title>
			<link>https://www.valueresearchonline.com/stories/26591/institutional-holding-nearing-limit/</link>
			<pubDate>Wed, 26 Nov 2014 12:05:00 +0530</pubDate>
			<category>Marketwire</category>
			<description>&lt;img src=&quot;https://www.valueresearchonline.com/content-assets/images/26591_26591__w320__h240__.jpg&quot; alt=&quot;Institutional Holding Nearing Limit&quot; border=&quot;0&quot; width=&quot;320&quot; height=&quot;240&quot; style=&quot;float: left; margin-right: 5px;&quot;&gt;Institutional holding in Nifty companies is steadily reaching their caps. What this means for the market?</description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/26591/institutional-holding-nearing-limit/</guid>
		</item>
		<item>
			<title>The Rupee Bonanza</title>
			<link>https://www.valueresearchonline.com/stories/23517/the-rupee-bonanza/</link>
			<pubDate>Thu, 05 Sep 2013 12:53:00 +0530</pubDate>
			<category>Special Report</category>
			<description>That rupee was in a downcast mood was evident since last year, but there are those that stand to gain from the decline></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/23517/the-rupee-bonanza/</guid>
		</item>
		<item>
			<title>Living The Larger Life</title>
			<link>https://www.valueresearchonline.com/stories/13109/living-the-larger-life/</link>
			<pubDate>Wed, 22 Apr 2009 10:44:00 +0530</pubDate>
			<category>Stock Ideas</category>
			<description>We take a look at mid-caps that have become large-caps, despite plummeting markets></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/13109/living-the-larger-life/</guid>
		</item>
		<item>
			<title>Déjà Vu All Over Again</title>
			<link>https://www.valueresearchonline.com/stories/11655/deja-vu-all-over-again/</link>
			<pubDate>Wed, 23 Jul 2008 11:20:00 +0530</pubDate>
			<category>Stock Analyst Choice</category>
			<description>The real estate sector&#039;s current fate is reminiscent of the dot-com bubble of yesteryears></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/11655/deja-vu-all-over-again/</guid>
		</item>
		<item>
			<title>Surreal… but Real</title>
			<link>https://www.valueresearchonline.com/stories/11436/surreal-but-real/</link>
			<pubDate>Fri, 06 Jun 2008 10:47:00 +0530</pubDate>
			<category>Stock Analyst Choice</category>
			<description>Despite the recent market meltdown, a few stocks posted positive returns. Read on to find out which></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/11436/surreal-but-real/</guid>
		</item>
		<item>
			<title>Zurich India Equity</title>
			<link>https://www.valueresearchonline.com/stories/1407/zurich-india-equity/</link>
			<pubDate>Mon, 29 Oct 2001 13:16:00 +0530</pubDate>
			<category>Fund Focus</category>
			<description>For its large-cap, quality stock biases and diversity as well as above average returns, Zurich India Equity is an attractive core holding for a growth portfolio></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/1407/zurich-india-equity/</guid>
		</item>
		<item>
			<title>Bulls Retreat After a Brief Outing</title>
			<link>https://www.valueresearchonline.com/stories/1403/bulls-retreat-after-a-brief-outing/</link>
			<pubDate>Sat, 27 Oct 2001 18:04:00 +0530</pubDate>
			<category>Stockwire</category>
			<description>With the earnings season coming to an end, the markets are expected to be lacklustre and wait fort the next trigger. The war continues to be the weak point for markets></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/1403/bulls-retreat-after-a-brief-outing/</guid>
		</item>
		<item>
			<title>Alliance Equity</title>
			<link>https://www.valueresearchonline.com/stories/1387/alliance-equity/</link>
			<pubDate>Mon, 22 Oct 2001 11:40:00 +0530</pubDate>
			<category>Fund Focus</category>
			<description>A confidence shaking performance in recent times should be overlooked in the favour of management&#039;s track record of putting up big numbers in the event of growth stocks outperforming the rest.></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/1387/alliance-equity/</guid>
		</item>
		<item>
			<title>Pharma Stocks prop Sentiment</title>
			<link>https://www.valueresearchonline.com/stories/1263/pharma-stocks-prop-sentiment/</link>
			<pubDate>Sat, 08 Sep 2001 17:21:00 +0530</pubDate>
			<category>Stockwire</category>
			<description>Domestic Pharma stocks were the only silver lining in the rangebound market. Near term, without any propellant the outlook remain bleak></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/1263/pharma-stocks-prop-sentiment/</guid>
		</item>
		<item>
			<title>Diversified Equity Funds: Not Dead Yet</title>
			<link>https://www.valueresearchonline.com/stories/1248/diversified-equity-funds-not-dead-yet/</link>
			<pubDate>Thu, 30 Aug 2001 17:11:00 +0530</pubDate>
			<category>Special Report</category>
			<description>Every bear phase finds doomsday prophetics, who torture data to pronounce the death of long-term equity investing. The truth prevails, even when the market is at its trough. The case for long-term investing in equities remains bright if not very strong.></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/1248/diversified-equity-funds-not-dead-yet/</guid>
		</item>
		<item>
			<title>Magnun Pharma Fund</title>
			<link>https://www.valueresearchonline.com/stories/1243/magnun-pharma-fund/</link>
			<pubDate>Mon, 27 Aug 2001 16:35:00 +0530</pubDate>
			<category>Fund Focus</category>
			<description>With a strong belief in the growth prospects of the Indian drug firms, Magnum Pharma could be well suited for a targeted diversification in pharmaceutical stocks.></description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/1243/magnun-pharma-fund/</guid>
		</item>
    </channel>
</rss>
